About
Dr Kate Rennie is a biomedical researcher at Newcastle University with 15+ years of interdisciplinary research spanning cancer biology, mitochondrial genetics, and clinical medicine. Her work demonstrates strong collaboration across departments including Medical Sciences and Clinical Research Institutes.
Her primary research interests include:
- Cancer Biology: Focusing on molecular mechanisms in osteosarcoma, prostate carcinoma, and acute lymphoblastic leukemia
- Mitochondrial Genetics: Investigating mtDNA mutations in metabolic disorders and neuronal development
- Clinical Translation: Bridging laboratory findings to patient care through clinical trials in ENT surgery and palliative care
Dr Rennie employs diverse methodologies from in vitro stem cell models to multicenter randomized controlled trials, consistently addressing translational research gaps between basic science and clinical applications.
Her publication record reveals an evolving trajectory from foundational mitochondrial research (2006-2009) through hematology/regenerative medicine (2014-2016) to contemporary clinical investigations (2020-2021). This progression highlights her adaptability across disciplines while maintaining focus on disease mechanisms and therapeutic outcomes, particularly in oncology and age-related conditions.
